Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Johnson

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Frontiers in Neurology|March 19, 2025
A patient-centered qualitative evaluation of meaningful change on the NSAA and PUL in Duchenne Muscular DystrophyAviva Gillman, Teofil Ciobanu, Louise Barrett, et al.
Orthopaedic Journal of Sports Medicine|November 23, 2020
Association Between MRI-Based Tibial Slope Measurements and Mucoid Degeneration of the Anterior Cruciate Ligament: A Propensity Score-Matched Case-Control StudyBashir Zikria, Alex Johnson, Nima Hafezi-Nejad, et al.
The Journal of Biological Chemistry|July 24, 2021
Sequence variation in the β7-β8 loop of bacterial class A sortase enzymes alters substrate selectivityIsabel M Piper, Sarah A Struyvenberg, Jordan D Valgardson, et al.
The Journal of Biological Chemistry|September 2, 2022
Structures of Streptococcus pyogenes class A sortase in complex with substrate and product mimics provide key details of target recognitionD Alex Johnson, Isabel M Piper, Brandon A Vogel, et al.
Plos Neglected Tropical Diseases|December 30, 2017
Discovery of novel, orally bioavailable, antileishmanial compounds using phenotypic screeningDiana Ortiz, W Armand Guiguemde, Jared T Hammill, et al.
Journal of Neuromuscular Diseases|November 19, 2023
Moving Beyond the 2018 Minimum International Care Considerations for Osteoporosis Management in Duchenne Muscular Dystrophy (DMD): Meeting Report from the 3rd International Muscle-Bone Interactions Meeting 7th and 14th November 2022Kim Phung, Nicola Crabtree, Anne M Connolly, et al.
The Lancet. Neurology|June 16, 2016
Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophyVolker Straub, Pavel Balabanov, Kate Bushby, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Frontiers in Neurology|March 19, 2025
A patient-centered qualitative evaluation of meaningful change on the NSAA and PUL in Duchenne Muscular DystrophyAviva Gillman, Teofil Ciobanu, Louise Barrett, et al.
Orthopaedic Journal of Sports Medicine|November 23, 2020
Association Between MRI-Based Tibial Slope Measurements and Mucoid Degeneration of the Anterior Cruciate Ligament: A Propensity Score-Matched Case-Control StudyBashir Zikria, Alex Johnson, Nima Hafezi-Nejad, et al.
The Journal of Biological Chemistry|July 24, 2021
Sequence variation in the β7-β8 loop of bacterial class A sortase enzymes alters substrate selectivityIsabel M Piper, Sarah A Struyvenberg, Jordan D Valgardson, et al.
The Journal of Biological Chemistry|September 2, 2022
Structures of Streptococcus pyogenes class A sortase in complex with substrate and product mimics provide key details of target recognitionD Alex Johnson, Isabel M Piper, Brandon A Vogel, et al.
Plos Neglected Tropical Diseases|December 30, 2017
Discovery of novel, orally bioavailable, antileishmanial compounds using phenotypic screeningDiana Ortiz, W Armand Guiguemde, Jared T Hammill, et al.
Journal of Neuromuscular Diseases|November 19, 2023
Moving Beyond the 2018 Minimum International Care Considerations for Osteoporosis Management in Duchenne Muscular Dystrophy (DMD): Meeting Report from the 3rd International Muscle-Bone Interactions Meeting 7th and 14th November 2022Kim Phung, Nicola Crabtree, Anne M Connolly, et al.
The Lancet. Neurology|June 16, 2016
Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophyVolker Straub, Pavel Balabanov, Kate Bushby, et al.
Pageof 5